XML 117 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information
 6 Months Ended
Jun. 30, 2022
Segment Reporting [Abstract]  
Segment Information

12. Segment Information

 

The Company’s nine businesses lines are organized, managed and internally reported as five operating segments. One of these operating segments, Product Packaging, is the Company’s packaging and printing group. Product Packaging operates in the paper board folding carton, smart packaging, and document security printing markets. It markets, manufactures, and sells mailers, photo sleeves, sophisticated custom folding cartons, and complex 3-dimensional direct mail solutions. These products are designed to provide functionality and marketability while also providing counterfeit protection. A second, Biotechnology, invests in, or acquires companies in the biohealth and biomedical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. This division is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Biotechnology is also targeting unmet, urgent medical needs. A third operating segment, Securities and Investment Management (“Securities”) was established to develop and/or acquire assets and investments in the securities trading and/or funds management arena. Further, Securities, in partnership with recognized global leaders in alternative trading systems, intends to own and operate in the US a single or multiple vertical digital asset exchanges for securities, tokenized assets, utility tokens, stable coins and cryptocurrency via a digital asset trading platform using blockchain technology. The scope of services within this section is planned to include asset issuance and allocation (securities and cryptocurrency), FPO, IPO, ITO, PPO, STO and UTO listings on a primary market(s), asset digitization/tokenization (securities, currency and cryptocurrency), and the listing and trading of digital assets (securities and cryptocurrency) on a secondary market(s). Also in this segment is the Company’s real estate investment trust (“REIT”), organized for the purposes of acquiring hospitals and other acute or post-acute care centers from leading clinical operators with dominant market share in secondary and tertiary markets, and leasing each property to a single operator under a triple-net lease. the REIT was formed to originate, acquire, and lease a credit-centric portfolio of licensed medical real estate. The fourth segment, Direct, provides services to assist companies in the emerging growth gig business model of peer-to-peer decentralized sharing marketplaces. It specializes in marketing and distributing its products and services through its subsidiary and partner network, using the popular gig economic marketing strategy as a form of direct marketing. Direct marketing products include, among other things, nutritional and personal care products sold throughout North America, Asia Pacific and Eastern Europe. The fifth business line, Commercial Banking, is organized for the purposes of being a financial network holding company, focused providing commercial loans and on acquiring equity positions in (i) undervalued commercial bank(s), bank holding companies and nonbanking licensed financial companies operating in the United States, South East Asia, Taiwan, Japan and South Korea, and (ii) companies engaged in—nonbanking activities closely related to banking, including loan syndication services, mortgage banking, trust and escrow services, banking technology, loan servicing, equipment leasing, problem asset management, SPAC (special purpose acquisition company) consulting, and advisory capital raising services. From this financial platform, the Company shall provide an integrated suite of financial services for businesses that shall include commercial business lines of credit, land development financing, inventory financing, third party loan servicing, and services that address the financial needs of the world Gig Economy.

 

Our segment structure presented below represents a change from the prior year for the inclusion of our Biotechnology, Securities, and Commercial Lending segments and the removal of our Plastics segment, Digital Group and IP Technology Management segment as the Plastics segment was discontinued in 2020, DSS Digital was sold and discontinued in May 2021 and activities surrounding our IP Technology Management segment have significantly decreased. The amounts for these segments have been included in the Corporate reporting segment for the six and three months ended June 30, 2022 and 2021, as necessary, below for reconciliation purposes.

 

Approximate information concerning the Company’s operations by reportable segment for the six and three months ended June 30, 2022 and 2021 is as follows. The Company relies on intersegment cooperation and management does not represent that these segments, if operated independently, would report the results contained herein:

 

 

                                    
Three Months Ended June 30, 2022  Product
Packaging		   Commercial
Lending		   Direct
Marketing		   Biotechnology   Securities   Corporate   Total 
Revenue  $3,599,000   $831,000   $6,111,000   $94,000   $823,000   $313,000   $11,771,000 
Depreciation and amortization   177,000    -    159,000    278,000    2,530,000    14,000    3,158,000 
Interest expense   34,000    -    (321,000)   -    408,000    -    121,000 
Interest income   1,000    

-

   2,000   91,000    34,000    11,000    139,000
Amortized debt discount   -    -    -    -    -    -    - 
Stock based compensation   -    -    -    -    -    -    - 
Net income (loss) from continuing operations   365,000    25,000    892,000    (673,000)   (3,332,000)   (2,687,000)   (5,410,000)
Capital expenditures   254,000    -    12,000    -    2,000    1,000    269,000 
Identifiable assets   26,688,000    52,416,000    52,267,000    56,524,000    85,436,000    9,617,000    282,948,000 

 

                                    
Three Months Ended June 30,2021 

Product

Packaging

  

Commercial

Lending

  

Direct

Marketing

   Biotechnology   Securities   Corporate   Total 
Revenue  $3,376,000   $-   $809,000   $-   $-   $-   $4,185,000 
Depreciation and amortization   191,000    -    274,000    278,000    -    74,000    817,000 
Interest expense   19,000    -    2,000    1,000    67,000    17,000    106,000 
Stock based compensation   1,000    -    -    -    -    (31,000)   (30,000)
Impairment of goodwill   -    -    -              -    - 
Net income (loss) from continuing operations   65,000    -    (5,985,000)   (610,000)   (173,000)   (4,022,000)   (10,725,000)
Capital expenditures   1,202,000    -    -    -    6,565,000    (57,000)   7,710,000 
Identifiable assets   29,463,000    -    44,772,000    53,717,000    10,939,000    52,270,000    191,161,000 

 

                                    
Six Months Ended June 30, 2022 

Product

Packaging

  

Commercial

Lending

  

Direct

Marketing

   Biotechnology   Securities   Corporate   Total 
Revenue  $7,168,000   $960,000   $13,043,000   $94,000   $2,497,000   $302,000   $24,064,000 
Depreciation and amortization   357,000    -    208,000    556,000    5,216,000    88,000    6,425,000 
Interest expense   58,000    -    -    -    1,441,000    -    1,499,000 
Stock based compensation   1,000    -    -    -    -    3,000    4,000 
Income tax benefit   -    -    -    -    -    -    - 
Net income (loss) from continuing operations   323,000    207,000    (3,472,000)   (1,289,000)   (5,838,000)   (4,292,000)   (14,361,000)
Capital expenditures   943,000    -    14,000    -    15,000    4,000    976,000 
Identifiable assets   26,688,000    52,416,000    52,267,000    56,524,000    85,436,000    9,617,000    282,948,000 

 

                                    
Six Months Ended June 30,2021 

Product

Packaging

  

Commercial

Lending

  

Direct

Marketing

   Biotechnology   Securities   Corporate   Total 
Revenue  $7,237,000   $-   $1,416,000   $-   $-   $-   $8,653,000 
Depreciation and amortization   307,000    -    319,000    556,000    -    153,000    1,335,000 
Interest expense   39,000    -    2,000    1,000    67,000    17,000    126,000 
Stock based compensation   1,000    -    -    -    -    (16,000)   (15,000)
Income tax benefit   -    -    -    -    -    

2,691,000

    

2,691,000

 
Net income (loss) from continuing operations   283,000    -    (7,785,000)   (1,308,000)   (231,000)   (5,746,000)   (14,787,000)
Capital expenditures   1,202,000    -    6,000    -    6,565,000    55,000    7,828,000 
Identifiable assets   29,463,000    -    44,772,000    53,717,000    10,939,000    52,270,000    191,161,000 

 

 

The following tables disaggregate our business segment revenues by major source:

 

Printed Products Revenue Information:

 

Six months ended June 30, 2022    
Packaging Printing and Fabrication  $7,468,000 
Commercial and Security Printing   149,000 
Total Printed Products  $7,617,000 

 

Six months ended June 30, 2021    
Packaging Printing and Fabrication  $7,056,000 
Commercial and Security Printing   181,000 
Total Printed Products  $7,237,000 

 

Direct Marketing

 

Six months ended June 30, 2022    
Direct Marketing Internet Sales  $13,002,000 
Total Direct Marketing  $13,002,000 

 

Six months ended June 30, 2021    
Direct Marketing Internet Sales  $1,416,000 
Total Direct Marketing  $1,416,000 

 

Rental Income

 

Six months ended June 30, 2022    
Rental income  $3,171,000 
Total Rental Income  $3,171,000 

 

Six months ended June 30, 2021     
Rental income  $- 
Total Rental Income  $- 

 

Net Investment Income

 

Three months ended March 31, 2022    
Net investment income  $274,000 
Total Management fee income  $274,000 

 

Three months ended March 31, 2021     
Management fee income  $- 
Total Management fee income  $-